Somalilandsun: China has been urged to join the COVAX facility in order to expand a globally equitable Covid-19 vaccine distribution.”
This follows the Emergency Use Listing (EUL) of China’s Sinopharm vaccine by the World Health organisation-WHO
This approval is prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.
Other vaccines with EUL status are Johnson & Johnson , Moderna, Pfizer and AstraZeneca all by the West thus making Sinopharm only one from the East as Russia’s Sputnik is yet to make the listing.
In a statement on the Sinopharm approval the WHO noted that “The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products. “We urge the manufacturer to participate in the COVAX Facility and contribute to the goal of more equitable vaccine distribution.”
Read full statement HERE
